Reference |
---|
Cousins H, Kline A, Wang C, Qu Y, Zengel J, Carette J, et al. Integrative analysis of functional genomic screening and clinical data identifies a protective role for spironolactone in severe COVID-19. Cell Rep Methods. 2023;3:100503 pubmed publisher
|
Li M, Du J, Liu W, Li Z, Lv F, Hu C, et al. Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. ISME J. 2023;17:549-560 pubmed publisher
|
Hou Y, Liu Y, Jia X, Zhou M, Mao W, Dong S, et al. Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library. Viruses. 2022;14: pubmed publisher
|
Deng T, Li T, Chen G, Zhu Y, Xu L, Lin Y, et al. Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation. Vaccine. 2022;40:6839-6848 pubmed publisher
|
Wang S, Wu D, Xiong H, Wang J, Tang Z, Chen Z, et al. Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines. Front Immunol. 2022;13:952650 pubmed publisher
|
Kazemi S, L xf3 pez Mu xf1 oz A, Holl xfd J, Jin L, Yewdell J, Dolan B. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. J Virol. 2022;96:e0025622 pubmed publisher
|
Xiong H, Sun H, Wang S, Yuan L, Liu L, Zhu Y, et al. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2. Proc Natl Acad Sci U S A. 2022;119:e2204256119 pubmed publisher
|
Biering S, Sarnik S, Wang E, Zengel J, Leist S, Sch xe4 fer A, et al. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection. Nat Genet. 2022;54:1078-1089 pubmed publisher
|
Wang Z, Xiang L, Lin F, Cai Z, Ruan H, Wang J, et al. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Matter. 2022;5:336-362 pubmed publisher
|
Cao J, Dong S, Liu Y, Zhou M, Guo J, Jia X, et al. Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library. Front Microbiol. 2021;12:793519 pubmed publisher
|
Kazemi S, López Muñoz A, Hollý J, Jin L, Yewdell J, Dolan B. Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs. bioRxiv. 2021;: pubmed publisher
|
Hennrich A, Sawatsky B, Santos Mandujano R, Banda D, Oberhuber M, Schopf A, et al. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. PLoS Pathog. 2021;17:e1009064 pubmed publisher
|
Addetia A, Lieberman N, Phung Q, Hsiang T, Xie H, Roychoudhury P, et al. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98. MBio. 2021;12: pubmed publisher
|
Liu Y, Guo J, Cao J, Zhang G, Jia X, Wang P, et al. Screening of Botanical Drugs against Lassa Virus Entry. J Virol. 2021;: pubmed publisher
|
Koenig P, Das H, Liu H, Kummerer B, Gohr F, Jenster L, et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science. 2021;: pubmed publisher
|
Mykytyn A, Breugem T, Riesebosch S, Schipper D, van den Doel P, Rottier R, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. elife. 2021;10: pubmed publisher
|
Farzani T, Chov A, Herschhorn A. A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses. STAR Protoc. 2020;1:100209 pubmed publisher
|
Mykytyn A, Lamers M, Okba N, Breugem T, Schipper D, van den Doel P, et al. Susceptibility of rabbits to SARS-CoV-2. Emerg Microbes Infect. 2021;10:1-7 pubmed publisher
|
Wang R, Simoneau C, Kulsuptrakul J, Bouhaddou M, Travisano K, Hayashi J, et al. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Cell. 2021;184:106-119.e14 pubmed publisher
|
Wang S, Li W, Hui H, Tiwari S, Zhang Q, Croker B, et al. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39:e106057 pubmed publisher
|
Xiong H, Wu Y, Cao J, Yang R, Liu Y, Ma J, et al. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells. Emerg Microbes Infect. 2020;9:2105-2113 pubmed publisher
|
Takahashi K, Yokobayashi Y. Reversible Gene Regulation in Mammalian Cells Using Riboswitch-Engineered Vesicular Stomatitis Virus Vector. ACS Synth Biol. 2019;8:1976-1982 pubmed publisher
|
Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, et al. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. J Virol. 2018;92: pubmed publisher
|
BEIER K, Saunders A, Oldenburg I, Miyamichi K, Akhtar N, Luo L, et al. Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors. Proc Natl Acad Sci U S A. 2011;108:15414-9 pubmed publisher
|